This may not be a universal feature, because in some cohorts high levels of fecal Faecalibacterium is associated with worse prognosis in patients with malignant melanoma and fecal butyrate limits the anticancer effect of CTLA-4 blockade (Coutzac et al. 2020). Here, CTLA4 is linked to melanoma.